FinData: News for NASDAQ, APRI

Thursday, 20 June 2013

Nexmed Inc.

Recent News

Apricus Biosciences Announces Poster Presentation of Vitaros ( R ) Data in Men ...
02:42 | 9/5/13

NASDAQ
SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www. more»
APRICUS BIOSCIENCES INC : Apricus Biosciences Announces First Quarter ...
08:52 | 8/5/13

4-traders
SAN DIEGO, April 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www. more»
Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men ...
03:01 | 8/5/13

GlobeNewswire
SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www. more»
Interview with the President and CEO: Innovus Pharmaceuticals, Inc. (INNV)
02:24 | 27/4/13

The Wall Street Transcript
Before joining Innovus Pharmaceuticals, Inc., Dr. Damaj served as President and Chief Executive Officer of Apricus Biosciences (APRI) from December 2009 until November 2012. At Apricus Bio, Dr. Damaj was responsible for the approval of its lead drug, ... more»
APRICUS BIOSCIENCES INC : Apricus Biosciences to Present at 2013 BIO ...
06:43 | 19/4/13

4-traders
SAN DIEGO, April 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www. more»
Apricus Biosciences to Present at 2013 BIO International Convention
23:01 | 18/4/13

MarketWatch
Apricus Biosciences, Inc. (NASDAQ:APRI) is a pharmaceutical company that develops and markets innovative treatments that help large patient populations across numerous, large-market therapeutic classes including male and female sexual health. more»
Zosano Pharma, Inc. Expands Board Of Directors With Addition Of Kleanthis G ...
03:00 | 16/4/13

Daily Markets
Dr. Xanthopoulos is a member of the Board of Directors of the Biotechnology Industry Organization (BIO), Apricus Biosciences, Sente Inc., and a member of the board of BIOCOM, Southern California's life science industry association. “I am delighted to ... more»
Apricus Offloads Non-Core Assets - Analyst Blog
10:14 | 5/4/13

NASDAQ
Apricus Biosciences, Inc . ( APRI ) recently announced that it has divested Totect and NitroMist. In Dec 2012, the company had decided to divest its oncology supportive care business, Apricus Pharmaceuticals. more»
Notable News: Nokia Corporation (ADR) (NYSE:NOK), Apricus Biosciences Inc ...
07:45 | 3/4/13

VB
Apricus Biosciences Inc. (NASDAQ:APRI) announced the sale of Totect and NitroMist and said of focusing its resources on commercializing its lead product Vitarosfor the treatment of erectile dysfunction (“ED”), and on the development of Femprox, for the ... more»
Daily Digest
13:35 | 2/4/13

San Diego Source (subscription)
Apricus Biosciences Inc. announced the sale of its Totect and Nitromist assets, and Life Technologies Corp. announced it has signed an agreement with LGC Forensics for the rights to distribute ParaDNA, a portable rapid DNA system, according to company ... more»

Global Indices

Code	Last	Change
NZ50	4,402	43	0.98%
COMP	3,443	39	1.12%
DJI	15,112	206	1.35%
SP500	1,629	23	1.39%
DAX	7,789	91	1.15%
FTSE	6,349	25	0.40%
NI225	12,494	22	0.18%
TWI	73.64	0.40	0.54%

More news...

No news available...

Currencies

Code	Last	Change
EURUSD	1.329	0.000	0.01%
NZDUSD	0.7885	0.0003	0.04%
AUDUSD	0.9305	0.0024	0.26%
NZDAUD	0.8471	0.0022	0.26%